Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
This report studies and analyses global Lanreotide Injection status and future trends, helps the client to determine the Lanreotide Injection market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Lanreotide Injection, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Lanreotide Injection market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Lanreotide Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Lanreotide Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Lanreotide Injection key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Lanreotide Injection key producing regions, capacity, production, and year over year growth
(6) Lanreotide Injection industry chains, upstream, midstream and downstream
According to YH Research, the global market for Lanreotide Injection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Lanreotide Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Lanreotide Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Market segment by players, this report covers
Ipsen
Cipla
Market segment by Type, covers
Sustained Release Formulation
Long-acting Formula
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Lanreotide Injection product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Lanreotide Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Lanreotide Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Lanreotide Injection, percent & CAGR, 2018-2029
Chapter 5: Lanreotide Injection industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Lanreotide Injection Definition
1.2 Global Lanreotide Injection Market Size and Forecast
1.2.1 By Consumption Value, Global Lanreotide Injection Market Size,2018-2029
1.2.2 By Sales Quantity, Global Lanreotide Injection Market Size,2018-2029
1.2.3 Global Lanreotide Injection Average Selling Price (ASP),2018-2029
1.3 China Lanreotide Injection Market Size and Forecast
1.3.1 By Consumption Value, China Lanreotide Injection Market Size,2018-2029
1.3.2 By Sales Quantity, China Lanreotide Injection Market Size,2018-2029
1.3.3 China Lanreotide Injection Average Selling Price (ASP), 2018-2029
1.4 Share of China Lanreotide Injection Market with Respect to the Global Market
1.4.1 By Consumption Value, China Lanreotide Injection Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Lanreotide Injection Market Share in Global, 2018-2029
1.4.3 Lanreotide Injection Market Size: China VS Global, 2018-2029
1.5 Lanreotide Injection Market Dynamics
1.5.1 Lanreotide Injection Market Drivers
1.5.2 Lanreotide Injection Market Restraints
1.5.3 Lanreotide Injection Industry Trends
1.5.4 Lanreotide Injection Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Lanreotide Injection, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Lanreotide Injection, Global Market Share by Company, 2018-2023
2.3 Lanreotide Injection Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Lanreotide Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Lanreotide Injection Concentration Ratio
2.6 Global Lanreotide Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Lanreotide Injection Manufacturers Product Type
2.8 Head Office and Lanreotide Injection Production Site of Key Manufacturer
2.9 Lanreotide Injection Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Lanreotide Injection, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Lanreotide Injection, China Market Share by Company, 2018-2023
3.3 China Lanreotide Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Lanreotide Injection Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Lanreotide Injection Capacity by Region
4.3 Global Lanreotide Injection Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Lanreotide Injection Production by Region, 2018-2029
4.5 Global Lanreotide Injection Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lanreotide Injection Industry Chain
5.2 Lanreotide Injection Upstream Analysis
5.2.1 Lanreotide Injection Core Raw Materials
5.2.2 Main Manufacturers of Lanreotide Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lanreotide Injection Production Mode
5.6 Lanreotide Injection Procurement Model
5.7 Lanreotide Injection Industry Sales Model and Sales Channels
5.7.1 Lanreotide Injection Sales Model
5.7.2 Lanreotide Injection Typical Distributors
6 Sights by Type
6.1 Lanreotide Injection Classification
6.1.1 Sustained Release Formulation
6.1.2 Long-acting Formula
6.2 By Type, Global Lanreotide Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lanreotide Injection Consumption Value, 2018-2029
6.4 By Type, Global Lanreotide Injection Sales Quantity, 2018-2029
6.5 By Type, Global Lanreotide Injection Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Lanreotide Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Lanreotide Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lanreotide Injection Consumption Value, 2018-2029
7.4 By Application, Global Lanreotide Injection Sales Quantity, 2018-2029
7.5 By Application, Global Lanreotide Injection Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lanreotide Injection Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Lanreotide Injection Consumption Value, 2018-2029
8.3 By Region, Global Lanreotide Injection Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Lanreotide Injection & Forecasts, 2018-2029
8.4.2 By Country, North America Lanreotide Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Lanreotide Injection Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lanreotide Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lanreotide Injection Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lanreotide Injection Market Size Market Share
8.7 South America
8.7.1 South America Lanreotide Injection Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lanreotide Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lanreotide Injection Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Lanreotide Injection Consumption Value, 2018-2029
9.3 By Country, Global Lanreotide Injection Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Lanreotide Injection Market Size, 2018-2029
9.4.2 By Type, U.S. Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lanreotide Injection Market Size, 2018-2029
9.5.2 By Type, Europe Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Lanreotide Injection Market Size, 2018-2029
9.6.2 By Type, China Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lanreotide Injection Market Size, 2018-2029
9.7.2 By Type, Japan Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lanreotide Injection Market Size, 2018-2029
9.8.2 By Type, South Korea Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lanreotide Injection Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Lanreotide Injection Market Size, 2018-2029
9.10.2 By Type, India Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Lanreotide Injection Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Ipsen
10.1.1 Ipsen Company Information, Head Office, Market Area, and Industry Position
10.1.2 Ipsen Lanreotide Injection Models, Specifications, and Application
10.1.3 Ipsen Lanreotide Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Ipsen Company Profile and Main Business
10.1.5 Ipsen Recent Developments
10.2 Cipla
10.2.1 Cipla Company Information, Head Office, Market Area, and Industry Position
10.2.2 Cipla Lanreotide Injection Models, Specifications, and Application
10.2.3 Cipla Lanreotide Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Cipla Company Profile and Main Business
10.2.5 Cipla Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Lanreotide Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lanreotide Injection Market Restraints
Table 3. Lanreotide Injection Market Trends
Table 4. Lanreotide Injection Industry Policy
Table 5. Global Lanreotide Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Lanreotide Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Lanreotide Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Lanreotide Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Lanreotide Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Lanreotide Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lanreotide Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Lanreotide Injection Manufacturers Product Type
Table 13. Head Office and Lanreotide Injection Production Site of Key Manufacturer
Table 14. Lanreotide Injection Capacity of Major Manufacturers and Future Plan
Table 15. China Lanreotide Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Lanreotide Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Lanreotide Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Lanreotide Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Lanreotide Injection Production by Region, 2018-2023, (K Units)
Table 20. Global Lanreotide Injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Lanreotide Injection Upstream (Raw Materials)
Table 22. Global Lanreotide Injection Typical Customers
Table 23. Lanreotide Injection Typical Distributors
Table 24. By Type, Global Lanreotide Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Lanreotide Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Lanreotide Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Lanreotide Injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Lanreotide Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Lanreotide Injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Lanreotide Injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Lanreotide Injection Sales Quantity Market Share, 2018-2029
Table 34. Ipsen Company Information, Head Office, Market Area, and Industry Position
Table 35. Ipsen Lanreotide Injection Models, Specifications, and Application
Table 36. Ipsen Lanreotide Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Ipsen Company Profile and Main Business
Table 38. Ipsen Recent Developments
Table 39. Cipla Company Information, Head Office, Market Area, and Industry Position
Table 40. Cipla Lanreotide Injection Models, Specifications, and Application
Table 41. Cipla Lanreotide Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Cipla Company Profile and Main Business
Table 43. Cipla Recent Developments
List of Figures
Figure 1. Lanreotide Injection Picture
Figure 2. Global Lanreotide Injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Lanreotide Injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Lanreotide Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Lanreotide Injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Lanreotide Injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Lanreotide Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Lanreotide Injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Lanreotide Injection Market Share of Global, 2018-2029
Figure 10. Global Lanreotide Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Lanreotide Injection Key Participants, Market Share, 2022
Figure 12. Global Lanreotide Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Lanreotide Injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Lanreotide Injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Lanreotide Injection Industry Chain
Figure 16. Lanreotide Injection Procurement Model
Figure 17. Lanreotide Injection Sales Model
Figure 18. Lanreotide Injection Sales Channels, Direct Sales, and Distribution
Figure 19. Sustained Release Formulation
Figure 20. Long-acting Formula
Figure 21. By Type, Global Lanreotide Injection Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Lanreotide Injection Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Lanreotide Injection Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Lanreotide Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. Others
Figure 29. By Application, Global Lanreotide Injection Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Lanreotide Injection Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Lanreotide Injection Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Lanreotide Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Lanreotide Injection Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Lanreotide Injection Sales Quantity Market Share, 2018-2029
Figure 36. North America Lanreotide Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Lanreotide Injection Consumption Value Market Share, 2022
Figure 38. Europe Lanreotide Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Lanreotide Injection Consumption Value Market Share, 2022
Figure 40. Asia Pacific Lanreotide Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Lanreotide Injection Consumption Value Market Share, 2022
Figure 42. South America Lanreotide Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Lanreotide Injection Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Lanreotide Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Lanreotide Injection Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Lanreotide Injection Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Reason to Buy